Qrxpharma - Latest News [Page 1]
FDA Grants QRxPharma Pre-New Drug Application Meeting
Monday, 21 February 2011, 12:39 pm | Qrxpharma
Sydney, Australia and Bedminster, New Jersey – QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today the granting of a pre-New Drug Application (NDA) meeting with the United States Food and Drug Administration (FDA) and successful completion ... More >>
Qrxpharma Initiates Second Pivotal Phase 3 Study
Wednesday, 10 February 2010, 1:33 pm | Qrxpharma
QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today initiation of its second pivotal Phase 3 registration trial (Study 009) to evaluate analgesic efficacy and safety of MoxDuo™IR, a patented 3:2 ratio fixed dose combination of morphine plus ... More >>
